Volume 69, no. 12, p. 7461-7470, 2001. Page 7461: The byline should read as shown above.
. 2002 May;70(5):2739. doi: 10.1128/IAI.70.5.2739.2002
Influence of Mycobacterium bovis Bacillus Calmette Guérin on In Vitro Induction of CD1 Molecules in Human Adherent Mononuclear Cells
Anna Giuliani
1, Salvatore P Prete
1, Grazia Graziani
1, Angelo Aquino
1, Alessandra Balduzzi
1, Masahiko Sugita
1, Michael B Brenner
1, Elisabetta Iona
1, Lanfranco Fattorini
1, Graziella Orefici
1, Steven A Porcelli
1, Enzo Bonmassar
1
Anna Giuliani
1Department of Neuroscience, University of Rome “Tor Vergata,” Institute of Neurobiology and Molecular Medicine, National Council of Research (CNR), Laboratory of Bacteriology and Medical Mycology, “Istituto Superiore di Sanità,” and “Istituto Dermopatico dell'Immacolata” (IDI-IRCCS), Rome, Italy; Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461
Find articles by Anna Giuliani
Salvatore P Prete
1Department of Neuroscience, University of Rome “Tor Vergata,” Institute of Neurobiology and Molecular Medicine, National Council of Research (CNR), Laboratory of Bacteriology and Medical Mycology, “Istituto Superiore di Sanità,” and “Istituto Dermopatico dell'Immacolata” (IDI-IRCCS), Rome, Italy; Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461
Find articles by Salvatore P Prete
Grazia Graziani
1Department of Neuroscience, University of Rome “Tor Vergata,” Institute of Neurobiology and Molecular Medicine, National Council of Research (CNR), Laboratory of Bacteriology and Medical Mycology, “Istituto Superiore di Sanità,” and “Istituto Dermopatico dell'Immacolata” (IDI-IRCCS), Rome, Italy; Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461
Find articles by Grazia Graziani
Angelo Aquino
1Department of Neuroscience, University of Rome “Tor Vergata,” Institute of Neurobiology and Molecular Medicine, National Council of Research (CNR), Laboratory of Bacteriology and Medical Mycology, “Istituto Superiore di Sanità,” and “Istituto Dermopatico dell'Immacolata” (IDI-IRCCS), Rome, Italy; Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461
Find articles by Angelo Aquino
Alessandra Balduzzi
1Department of Neuroscience, University of Rome “Tor Vergata,” Institute of Neurobiology and Molecular Medicine, National Council of Research (CNR), Laboratory of Bacteriology and Medical Mycology, “Istituto Superiore di Sanità,” and “Istituto Dermopatico dell'Immacolata” (IDI-IRCCS), Rome, Italy; Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461
Find articles by Alessandra Balduzzi
Masahiko Sugita
1Department of Neuroscience, University of Rome “Tor Vergata,” Institute of Neurobiology and Molecular Medicine, National Council of Research (CNR), Laboratory of Bacteriology and Medical Mycology, “Istituto Superiore di Sanità,” and “Istituto Dermopatico dell'Immacolata” (IDI-IRCCS), Rome, Italy; Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461
Find articles by Masahiko Sugita
Michael B Brenner
1Department of Neuroscience, University of Rome “Tor Vergata,” Institute of Neurobiology and Molecular Medicine, National Council of Research (CNR), Laboratory of Bacteriology and Medical Mycology, “Istituto Superiore di Sanità,” and “Istituto Dermopatico dell'Immacolata” (IDI-IRCCS), Rome, Italy; Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461
Find articles by Michael B Brenner
Elisabetta Iona
1Department of Neuroscience, University of Rome “Tor Vergata,” Institute of Neurobiology and Molecular Medicine, National Council of Research (CNR), Laboratory of Bacteriology and Medical Mycology, “Istituto Superiore di Sanità,” and “Istituto Dermopatico dell'Immacolata” (IDI-IRCCS), Rome, Italy; Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461
Find articles by Elisabetta Iona
Lanfranco Fattorini
1Department of Neuroscience, University of Rome “Tor Vergata,” Institute of Neurobiology and Molecular Medicine, National Council of Research (CNR), Laboratory of Bacteriology and Medical Mycology, “Istituto Superiore di Sanità,” and “Istituto Dermopatico dell'Immacolata” (IDI-IRCCS), Rome, Italy; Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461
Find articles by Lanfranco Fattorini
Graziella Orefici
1Department of Neuroscience, University of Rome “Tor Vergata,” Institute of Neurobiology and Molecular Medicine, National Council of Research (CNR), Laboratory of Bacteriology and Medical Mycology, “Istituto Superiore di Sanità,” and “Istituto Dermopatico dell'Immacolata” (IDI-IRCCS), Rome, Italy; Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461
Find articles by Graziella Orefici
Steven A Porcelli
1Department of Neuroscience, University of Rome “Tor Vergata,” Institute of Neurobiology and Molecular Medicine, National Council of Research (CNR), Laboratory of Bacteriology and Medical Mycology, “Istituto Superiore di Sanità,” and “Istituto Dermopatico dell'Immacolata” (IDI-IRCCS), Rome, Italy; Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461
Find articles by Steven A Porcelli
Enzo Bonmassar
1Department of Neuroscience, University of Rome “Tor Vergata,” Institute of Neurobiology and Molecular Medicine, National Council of Research (CNR), Laboratory of Bacteriology and Medical Mycology, “Istituto Superiore di Sanità,” and “Istituto Dermopatico dell'Immacolata” (IDI-IRCCS), Rome, Italy; Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461
Find articles by Enzo Bonmassar
1Department of Neuroscience, University of Rome “Tor Vergata,” Institute of Neurobiology and Molecular Medicine, National Council of Research (CNR), Laboratory of Bacteriology and Medical Mycology, “Istituto Superiore di Sanità,” and “Istituto Dermopatico dell'Immacolata” (IDI-IRCCS), Rome, Italy; Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115; and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461
Copyright © 2002, American Society for Microbiology
PMCID: PMC127955
This corrects the article "Influence of Mycobacterium bovis Bacillus Calmette Guérin on In Vitro Induction of CD1 Molecules in Human Adherent Mononuclear Cells" in volume 69 on page 7461.